Rwanda Day: President Kagame urges connection

Rwanda Day, an event that celebrates Rwandan culture and aims to foster a connection between Rwandans living abroad and their homeland, took place in Washington DC recently. President Paul Kagame used this platform to call on the Rwandan diaspora to stay connected to their roots and play a significant role in the development of Rwanda. He highlighted the importance of maintaining ties with Rwanda, regardless of where individuals may find themselves in the world. One of the key announcements made during the event was by the Rwandan biotech firm Akagera Medicines, which revealed that they had successfully raised 12 million euros for capacity building and other projects. This investment signals a positive step towards enhancing Rwanda's healthcare and pharmaceutical sector. President Kagame emphasized the significance of the Rwandan diaspora in contributing to the country's growth and progress. He specifically extended a job offer to young Rwandans with expertise in science, medicine, and business development in the science sector to consider returning to Rwanda to be part of the country's development journey. With the substantial financial resources available for investment in various sectors, Rwanda continues to pave the way for innovation and advancement. The substantial increase in remittances from the diaspora is a testament to the strong bond that Rwandans around the world feel towards their homeland. From $65.1 million in 2010 to a remarkable $470 million in 2023, these remittances play a crucial role in supporting families, businesses, and overall economic growth in Rwanda. Akagera Medicines, as the continent's only African-owned biotechnology company based in Rwanda, is making significant strides in the field of healthcare and pharmaceuticals. With a portfolio that includes vaccines, drugs, and upcoming human trials, the firm has garnered support from prestigious organizations such as the Gates Foundation, the European Investment Bank, and the European Union. Looking ahead, Akagera Medicines is set to receive a substantial $40 million investment from a renowned academic consortium, further solidifying its position as a leading player in the biotechnology sector. Plans for growth and expansion over the next few years will be presented to the Rwanda Social Security Board, indicating a strategic roadmap for the company's future endeavors. President Kagame's call for the diaspora to maintain ties with Rwanda and actively participate in its development echoes a sentiment of unity and progress. By harnessing the skills and expertise of Rwandans across the globe, the country is poised to achieve even greater milestones in areas such as healthcare, technology, and innovation. The bond between Rwanda and its diaspora continues to strengthen, paving the way for a brighter and more prosperous future for all.